ArticleCurrent oncology (Toronto, Ont.)2012

Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

S D Young et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.